Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
(2015) In Journal of Clinical Pathology 68(12). p.1012-1019- Abstract
- Aldehyde dehydrogenase family 1 member A1 (ALDH1A1) is a putative marker of breast cancer stem cells (CSCs) with prognostic implications when expressed in cancer or stroma. However, previous results are contradictory and we therefore aimed to further evaluate the impact of ALDH1A1 on distant disease-free survival (DDFS) and correlation with clinicopathological variables in breast cancer, specifically by evaluating different cut-offs.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7749569
- author
- Sjöström, Martin LU ; Werner Hartman, Linda LU ; Honeth, Gabriella LU ; Grabau, Dorthe LU ; Malmström, Per LU ; Hegardt, Cecilia LU ; Fernö, Mårten LU and Niméus, Emma LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Pathology
- volume
- 68
- issue
- 12
- pages
- 1012 - 1019
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:26175266
- wos:000365340200009
- scopus:84958180531
- pmid:26175266
- ISSN
- 1472-4146
- DOI
- 10.1136/jclinpath-2015-203092
- language
- English
- LU publication?
- yes
- id
- 35172bc6-2797-4032-8e99-52b56f39d87f (old id 7749569)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26175266?dopt=Abstract
- date added to LUP
- 2016-04-01 10:23:45
- date last changed
- 2022-04-25 12:53:13
@article{35172bc6-2797-4032-8e99-52b56f39d87f, abstract = {{Aldehyde dehydrogenase family 1 member A1 (ALDH1A1) is a putative marker of breast cancer stem cells (CSCs) with prognostic implications when expressed in cancer or stroma. However, previous results are contradictory and we therefore aimed to further evaluate the impact of ALDH1A1 on distant disease-free survival (DDFS) and correlation with clinicopathological variables in breast cancer, specifically by evaluating different cut-offs.}}, author = {{Sjöström, Martin and Werner Hartman, Linda and Honeth, Gabriella and Grabau, Dorthe and Malmström, Per and Hegardt, Cecilia and Fernö, Mårten and Niméus, Emma}}, issn = {{1472-4146}}, language = {{eng}}, number = {{12}}, pages = {{1012--1019}}, publisher = {{BMJ Publishing Group}}, series = {{Journal of Clinical Pathology}}, title = {{Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.}}, url = {{http://dx.doi.org/10.1136/jclinpath-2015-203092}}, doi = {{10.1136/jclinpath-2015-203092}}, volume = {{68}}, year = {{2015}}, }